Latest Stock Market News

Bitcoin surged past $93,000, fueled by positive remarks from U.S. President Trump and easing global tensions. Ethereum also jumped, leading a broad altcoin rally. Increased institutional buying, with Bitcoin spot ETFs seeing significant inflows, and a shift in investor sentiment contributed to the surge.

Technical analysts are starting to suggest that the markets may be approaching overbought conditions, a situation that often triggers profit-taking. Yet, just as the market seemed poised for a pause, the global outlook took a more positive turn, boosting sentiment once again.

NSE s MD & CEO, Ashishkumar Chauhan, highlights Nifty s impressive 24-fold growth in 29 years, surpassing gold and S&P 500 returns. He anticipates a similar surge by 2047, driven by India s rapid growth, technological adaptation, and rising entrepreneurship. Chauhan advises retail investors to maintain a long-term perspective to navigate market fluctuations and reap the benefits.

AU Small Finance Bank s shares soared following a robust Q4 net profit increase of 36% to Rs 504 crore, driven by strong income growth and improved asset quality. Net interest income surged 57% to ₹2,094 crore, boosting pre-provisioning operating profit.

Amidst volatile equity markets, investors are increasingly seeking stability in fixed income options like corporate bonds and debt funds. Experts suggest that potential rate cuts and geopolitical risks make fixed-return investments appealing for the next 2-3 years.

Axis Bank is expected to post modest 5% YoY growth in net interest income for Q4, with flat margins and stable asset quality. Profit may decline 3% YoY amid sluggish loan growth and fee income. Analysts highlight deposit traction, slippages, and credit cost as key monitorables.

Systematix Group s Vishal Manchanda anticipates Q4 results for pharma companies to align with previous quarters, with high single-digit domestic growth. US growth, driven by high-value launches for companies like Zydus and Sun Pharma, is considered tactical and unsustainable. He suggests caution towards companies heavily exposed to US generics due to price erosion and potential tariffs.

Hindustan Unilever is likely to report muted Q4FY25 results with 2% revenue growth and flat volumes due to urban slowdown, high input costs, and rising competition. Margins remain under pressure, though cost controls may aid EBITDA. Demand recovery remains key.